FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected

A panel of expert advisers to the U.S. Food and Drug Administration is expected to recommend authorization of a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, setting the stage for the roll out of a third approved vaccine in the U.S. next week. Fred Katayama reports.